Navigation Links
New atherosclerosis vaccine gives promising results
Date:5/6/2010

e LDL can block the immune reaction and reduce the disease by between 60 and 70 per cent. The vaccine has been successfully tested on animals and the researchers are now hoping to see if it can be developed into a treatment for patients with a high risk of myocardial infarction and stroke.

The researchers also now believe that their results explain why antioxidants are ineffective against cardiovascular disease when they have been tested in large clinical studies.

"If one takes antioxidants, one simply prevents the oxidation of LDL," says Professor Hansson. "It retains its ability to activate the T cells, and so the inflammation in the blood vessels can increase. This could give the opposite results to what one was hoping for."


'/>"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-085-248-3895
Karolinska Institutet
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Researchers identify a gene that may play a key role in atherosclerosis and other diseases
2. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
3. Resverlogix Commences Phase 2 Atherosclerosis Clinical Trial
4. AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
5. Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
6. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
7. Old and new therapies combine to tackle atherosclerosis
8. Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Programs in the Developing World
9. New inhalable measles vaccine may lead to vaccines for other diseases
10. Archivel Farmas TB Vaccine May Cut Treatment Time From Nine Months to One
11. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... James Sherley says he has been working ... cell technology since his days as a principal investigator at ... late 1990’s. Sherley founded the ASCTC as a new ... the intellectual property developed in Sherley’s research over the years ... of Technology (MIT), and more recently as a senior scientist ...
(Date:10/30/2014)... 30, 2014 Grace Century portfolio project, ... Manganello, Chairman of the Board, to the National Stem ... appointment was made by the Ministry of Health on behalf ... , More than a year after Bahamian Parliament ... Prime Minister Perry Christie said the government has completed the ...
(Date:10/30/2014)... of the key challenges in the development of quantum ... , In a paper published today (28 October) in ... show how to make a new type of flexibly ... such as high-precision sensors and specialised superfast computers, often ... the methods for trapping these tiny particles are hugely ...
(Date:10/27/2014)... , October 27, 2014 ... right to produce, exhibit and sell its artificial ... to impeach their patent.      (Photo: ... four years of fighting, the definitive judgement has ... and produces innovative and accessible hi-tech prostheses with ...
Breaking Biology Technology:Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2
... NeuroCog Trials, Inc. today announced the appointment of Michael ... Officer.  In this newly created position, Dr. Hufford will ... NeuroCog Trials, business, research and development, and operations. ... therapies across a wide variety of therapeutic areas has ...
... November 4, 2011 Major milestone achieved ... treatment of patients with refractory ascites due to liver ... Vienna and Vienna General Hospital (AKH Wien) reported that ... System were performed at Vienna General Hospital in October, ...
... Nov. 3, 2011 Sequenom, Inc. (NASDAQ: SQNM ), ... total revenues of $13.6 million for the third quarter of 2011, ... the third quarter of 2010.  Net loss for the third quarter ... to net loss of $22.7 million, or $0.30 per share for ...
Cached Biology Technology:NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer 2The Medical University of Vienna and Vienna General Hospital Perform the First two Commercial Implants Worldwide of Sequana Medical's ALFApump® System 2Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 2Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 3Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 4Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 5Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 6Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 7Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 8
(Date:10/30/2014)... University researchers have developed a suite of technologies that ... humans, which has applications in everything from search and ... "We,ve developed a platform for computer-mediated communication between humans ... for interpreting dogs, behavioral signals and sending them clear ... an assistant professor of computer science at NC State ...
(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... factors, both genetic and environmental, have been blamed ... schizophrenia. Some, such as a family history of ... with Toxoplasma gondii , a parasite transmitted ... still viewed with skepticism. , A new study ... epidemiology at the University of Pennsylvania,s School of ...
Breaking Biology News(10 mins):New tech aims to improve communication between dogs and humans 2New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3
... have found that a strain of tuberculosis (TB) responsible ... first introduced to these communities by French Canadian fur ... found a traceable link between the fur trade routes ... professor with Queen,s Division of Infectious Diseases, is the ...
... Melding nanotechnology and medical research, Sandia National Laboratories, the ... and Treatment Center have produced an effective strategy that ... of killer drugs. , In the cover article of ... online April 17 , the researchers describe silica nanoparticles ...
... Monday, April 18, 2011, Cleveland: Researchers have identified ... as the cause of a fatal developmental disease in ... April 8, 2011, issue of Science . ... the cellular protein-making process, causing microcephalic osteodysplastic primoridal dwarfism ...
Cached Biology News:Tuberculosis strain in indigenous communities linked to Canadian fur trade 2Sandia and UNM lead effort to destroy cancers 2Sandia and UNM lead effort to destroy cancers 3Genetic mutation linked to lethal disease 2
Chicken Anti-Human Stomatin-like 2 (STOML2 Polyclonal AntibodyNew Applications: ELISA, Western Blot...
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
... (Ankyrin repeat and SOCS box-containing protein) This ... containing amino acids 75-93 and 348-368 of ... Catalog No. 40149) can be used as ... with mouse and rat Asb-2, based on ...
Monoclonal Anti-Gα o purified immunoglobulin buffered aqueous solution Solution in phosphate buffered saline pH 7.4, containing 0.08% sodium azide. partially purified bovine brain Gα O ...
Biology Products: